The feasibility of additional CD19-targeted cellular therapy in relapsed/refractory B-ALL with re-emergence of CD19 antigen after prior CD19-negative relapse

被引：2
|
作者：
Agrawal, Vaibhav [1 ,2 ]
Salhotra, Amandeep [1 ,2 ]
Song, Joo [3 ]
Gu, Zhaohui [3 ,4 ]
Stein, Anthony S. [1 ,2 ]
Marcucci, Guido [1 ,2 ]
Forman, Stephen J. [1 ,2 ]
Pullarkat, Vinod [1 ,2 ]
Aldoss, Ibrahim [1 ,2 ,5 ]
机构：
[1] City Hope Natl Med Ctr, Gehr Family Ctr Leukemia Res, Dept Hematol & Hematopoiet Cell Transplantat, Duarte, CA USA
[2] City Hope Natl Med Ctr, Dept Pathol, Duarte, CA USA
[3] Beckman Res Inst City Hope, Dept Computat & Quantitat Med, Duarte, CA USA
[4] Beckman Res Inst City Hope, Dept Syst Biol, Duarte, CA USA
[5] City Hope Natl Med Ctr, Gehr Family Ctr Leukemia Res, Dept Hematol & Hematopoiet Cell Transplantat, Duarte, CA 91010 USA
来源：
AMERICAN JOURNAL OF HEMATOLOGY | 2023年 / 98卷 / 02期
关键词：
BLINATUMOMAB; RESISTANCE;
D O I：
10.1002/ajh.26787
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：E38 / E40
页数：3
相关论文
共 50 条
  • [31] A Refractory B-ALL Patient Relapsed with Leukemia Cells Expressing CD19 and Anti-CD19 CAR Gene 14 Days after CR from Anti-CD19 CAR T-Cell Therapy
    Liu Meijing
    Cui, Rui
    Mu, Juan
    Yuan, Ji-Jun
    Mou, Nan
    Yang, Zhen-xing
    Jiang Yan-yu
    Meng Juanxia
    Deng, Qi
    BLOOD, 2019, 134
  • [32] Efficacy and Safety of CAR T-Cell Therapy Using a Fully Human CD19-Targeted Binder in Adults with Relapsed/ Refractory B-ALL
    Gauthier, Jordan
    Gazeau, Nicolas
    Fiorenza, Salvatore
    Kimble, Erik L.
    Hirayama, Alexandre Vinaud
    Pender, Barbara S.
    Di, Henna N.
    Kirchmeier, Delaney R.
    Shadman, Mazyar
    Cassaday, Ryan D.
    Riddell, Stanley R.
    Maloney, David G.
    Turtle, Cameron J.
    BLOOD, 2022, 140 : 10360 - 10362
  • [33] A retrospective comparison of CD19 single and CD19/CD22 bispecific targeted chimeric antigen receptor T cell therapy in patients with relapsed/refractory acute lymphoblastic leukemia
    Wang, Yiyun
    Yang, Yingying
    Hong, Ruimin
    Zhao, Houli
    Wei, Guoqing
    Wu, Wenjun
    Xu, Huijun
    Cui, Jiazhen
    Zhang, Yanlei
    Chang, Alex H.
    Hu, Yongxian
    Huang, He
    BLOOD CANCER JOURNAL, 2020, 10 (10)
  • [34] A retrospective comparison of CD19 single and CD19/CD22 bispecific targeted chimeric antigen receptor T cell therapy in patients with relapsed/refractory acute lymphoblastic leukemia
    Yiyun Wang
    Yingying Yang
    Ruimin Hong
    Houli Zhao
    Guoqing Wei
    Wenjun Wu
    Huijun Xu
    Jiazhen Cui
    Yanlei Zhang
    Alex H. Chang
    Yongxian Hu
    He Huang
    Blood Cancer Journal, 10
  • [35] SALVAGE THERAPIES AND OUTCOMES OF PATIENTS WITH RELAPSE OF B-ALL AFTER CD19 CAR T-CELL THERAPY
    Friedes, Barbara
    DiNofia, Amanda
    Li, Yimei
    Iannone, Emma
    Rheingold, Susan
    Leahy, Allison Barz
    Wray, Lisa
    Callahan, Colleen
    Baniewicz, Diane
    Liu, Hongyan
    Getz, Kelly
    Aplenc, Richard
    Maude, Shannon
    Grupp, Stephan
    Myers, Regina
    PEDIATRIC BLOOD & CANCER, 2023, 70 : S54 - S54
  • [36] A review of CD19-targeted immunotherapies for relapsed or refractory acute lymphoblastic leukemia
    DasGupta, Ryan K.
    Marini, Bernard L.
    Rudoni, Joslyn
    Perissinotti, Anthony J.
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2018, 24 (06) : 453 - 467
  • [37] Extracellular Vesicles Expressing CD19 Antigen Improve Expansion and Efficacy of CD19-Targeted CAR-T Cells
    Zhang, Yuanyuan
    Ge, Tong
    Huang, Meijuan
    Qin, Yun
    Liu, Tianjiao
    Mu, Wei
    Wang, Gaoxiang
    Jiang, Lijun
    Li, Tongjuan
    Zhao, Lei
    Wang, Jue
    INTERNATIONAL JOURNAL OF NANOMEDICINE, 2023, 18 : 49 - 63
  • [38] Phase I Clinical Trial of Autologous CD19-Targeted 19-28z CAR T Cells in Adult Patients With Relapsed or Refractory B-ALL
    Park, Jae H.
    Riviere, Isabelle
    Wang, Xiuyan
    Bernal, Yvette
    Halton, Elizabeth
    Quintanilla, Hilda
    Curran, Kevin
    Sauter, Craig
    Sadelain, Michel
    Brentjens, Renier J.
    MOLECULAR THERAPY, 2015, 23 : S188 - S189
  • [39] Safe and Effective Re-Induction Of Complete Remissions In Adults With Relapsed B-ALL Using 19-28z CAR CD19-Targeted T Cell Therapy
    Davila, Marco L.
    Riviere, Isabelle
    Wang, Xiuyan
    Bartido, Shirley
    Stefanski, Jolanta
    He, Qing
    Borquez-Ojeda, Oriana
    Taylor, Clare
    Wasielewska, Teresa
    Qu, Jinrong
    Bouhassira, Diana C. G.
    Bernal, Yvette J.
    Yoo, Sarah
    Purdon, Terence
    Halton, Elizabeth
    Quintanilla, Hilda
    Park, Jae H.
    Curran, Kevin J.
    Sadelain, Michel
    Brentjens, Renier J.
    BLOOD, 2013, 122 (21)
  • [40] Acute lymphoblastic leukemia relapse after CD19-targeted chimeric antigen receptor T cell therapy
    Wang, Jiasheng
    Hu, Yongxian
    Huang, He
    JOURNAL OF LEUKOCYTE BIOLOGY, 2017, 102 (06) : 1347 - 1356
12345